BAKU, Azerbaijan, September 13. The initiation of the first phase of BioPharmax's Israeli Company production activity in Alat Free Economic Zone (AFEZ) on the territory of Azerbaijan is planned for autumn 2023, CEO of BioPharmax Israeli company Sarel Chen-Tov told Trend.
According to him, expansion of production and the start of full production capacity are planned closer to 2025.
"Firstly, it's planned to establish the production of medications and medical equipment for which the company sees the greatest demand," Sarel Chen-Tov said.
BioPharmax will produce medication and medical equipment in Azerbaijan. It's also planned to create a laboratory center together with Azerbaijani medical institutions and universities.
